Literature DB >> 9119812

Combined aortic and mitral valve replacement in an adult with mucopolysaccharidosis (Maroteaux-Lamy syndrome).

M Hachida1, M Nonoyama, Y Bonkohara, N Hanayama, H Koyanagi.   

Abstract

A 41-year-old man with aortic stenosis, mitral stenosis, and tricuspid regurgitation due to Maroteaux-Lamy syndrome underwent aortic and mitral valve replacement with tricuspid annuloplasty. The annular diameter of the aortic and mitral valves was extremely small. The valve prostheses were 19 mm in diameter in the aortic position and 25 mm in the mitral position. Histologically, the valves showed thickening and hyalinization of the collagen fibers, and the presence of foamy cells that contained a large quantity of pure acid mucopolysaccharide. On an echocardiographic examination performed 2 years after the surgery, the peak systolic gradient of the trans-aortic valve was 18 mmHg at rest, and 26 mmHg during exercise. Careful observation of the residual pressure gradient will be needed. The patient's present New York Heart Association (NYHA) status is grade I and he has returned to work.

Entities:  

Mesh:

Year:  1996        PMID: 9119812     DOI: 10.1007/bf02559995

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  8 in total

1.  [A NEW DYSOSTOSIS WITH URINARY ELIMINATION OF CHONDROITIN SULFATE B].

Authors:  P MAROTEAUX; B LEVEQUE; J MARIE; M LAMY
Journal:  Presse Med       Date:  1963-09-25       Impact factor: 1.228

2.  Cardiovascular studies in the mucopolysaccharidoses.

Authors:  J Nelson; M D Shields; H C Mulholland
Journal:  J Med Genet       Date:  1990-02       Impact factor: 6.318

3.  Valvular heart disease in four patients with Maroteaux-Lamy syndrome.

Authors:  C T Tan; H V Schaff; F A Miller; W D Edwards; P S Karnes
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

4.  Type 3 mucopolysaccharidosis: report of a case with severe mitral valve involvement.

Authors:  J K Herd; S Subramanian; H Robinson
Journal:  J Pediatr       Date:  1973-01       Impact factor: 4.406

5.  Combined aortic and mitral valve replacement in an adult with Scheie's disease.

Authors:  S M Butman; L Karl; J G Copeland
Journal:  Chest       Date:  1989-07       Impact factor: 9.410

6.  Cardiac manifestations of the mucopolysaccharidoses.

Authors:  R M Schieken; R E Kerber; V V Ionasescu; H Zellweger
Journal:  Circulation       Date:  1975-10       Impact factor: 29.690

7.  Aortic stenosis and mucopolysaccharidosis.

Authors:  C S Wilson; H T Mankin; J R Pluth
Journal:  Ann Intern Med       Date:  1980-04       Impact factor: 25.391

8.  Mild form of Hunter's syndrome: clinical delineation based on 31 cases.

Authors:  I D Young; P S Harper
Journal:  Arch Dis Child       Date:  1982-11       Impact factor: 3.791

  8 in total
  4 in total

Review 1.  Surgical Management of Valvular Heart Disease in Mucopolysaccharidoses: A Review of Literature.

Authors:  Barbara A Rosser; Calvin Chan; Andreas Hoschtitzky
Journal:  Biomedicines       Date:  2022-02-04

2.  Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy.

Authors:  E Braunlin; H Rosenfeld; C Kampmann; J Johnson; M Beck; R Giugliani; N Guffon; D Ketteridge; C M Sá Miranda; M Scarpa; I V Schwartz; E Leão Teles; J E Wraith; P Barrios; E Dias da Silva; G Kurio; M Richardson; G Gildengorin; J J Hopwood; M Imperiale; A Schatz; C Decker; P Harmatz
Journal:  J Inherit Metab Dis       Date:  2012-06-05       Impact factor: 4.982

Review 3.  Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management.

Authors:  Elizabeth A Braunlin; Paul R Harmatz; Maurizio Scarpa; Beatriz Furlanetto; Christoph Kampmann; James P Loehr; Katherine P Ponder; William C Roberts; Howard M Rosenfeld; Roberto Giugliani
Journal:  J Inherit Metab Dis       Date:  2011-07-09       Impact factor: 4.982

Review 4.  Pre-operative Considerations in Adult Mucopolysaccharidosis Patients Planned for Cardiac Intervention.

Authors:  Benjamin Cross; Karolina M Stepien; Chaitanya Gadepalli; Ahmed Kharabish; Peter Woolfson; Govind Tol; Petra Jenkins
Journal:  Front Cardiovasc Med       Date:  2022-04-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.